Raising the Bar for Dietary Supplement Clinical Trials

February 15, 2012

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

Already have an account?

Double blind, randomized controlled trials (DBRCTs) are generally perceived to be the gold standard for clinical trials. While DBRCTs clearly can produce high-quality data, it is important to question the quality of the trial design, trial conduct clinical data management, statistical analysis and interpretation.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like